Skip to main
![genemod_Logo]()
Why FreezerPro Is No Longer Enough for Modern Sample Management — And What Scaling Labs Need Instead
FreezerPro focuses on freezer tracking, but modern labs need lifecycle-aware, connected inventory management. Learn why scaling teams choose Genemod for stronger sample management and unified lab operations.
All
Data Management
Scientific Research
What's new
Events
Why FreezerPro Is No Longer Enough for Modern Sample Management — And What Scaling Labs Need Instead
FreezerPro focuses on freezer tracking, but modern labs need lifecycle-aware, connected inventory management. Learn why scaling teams choose Genemod for stronger sample management and unified lab operations.
February 12, 2026
Top 10 Biotech Companies in London to Watch Leading Into 2026
Explore 10 London-based biotech companies to watch heading into 2026, spanning cell and gene therapy, AI-driven drug discovery, RNA therapeutics, and next-generation immunology.
February 11, 2026
Top 10 Biotech Companies to Watch in Raleigh in 2026
Raleigh’s biotech ecosystem is gaining momentum heading into 2026. Explore 10 Raleigh-based biotech companies to watch, spanning therapeutics, gene therapy, antibiotics, and emerging platforms.
February 09, 2026
Reimagining Lab Software at SLAS 2026: Why AI-Driven LIMS Is the Next Frontier
SLAS 2026 highlights the rise of AI-driven LIMS and lab management software. Learn what defines a true AI LIMS, key trends from the event, and visit Genemod at Booth #1835.
February 06, 2026
Flexibility of Data Analysis Through AI: Why Genemod’s Data Platform Matters
Flexible AI-driven analysis depends on connected lab data. Learn how Genemod’s unified data platform enables sample-aware, operational, and adaptable analytics for modern R&D teams in 2026.
February 03, 2026
Top 10 Biotech Companies in New York to Watch Leading Into 2026
New York’s biotech ecosystem is accelerating into 2026. Explore 10 New York–based biotech companies to watch, spanning translational medicine, AI-driven discovery, and next-generation therapeutics.
January 30, 2026
